This digitally-colorized transmission electron microscopic (TEM) image revealed the presence of hepatitis B virions. (CDC/ Dr. Erskine Palmer)

Our New Quantitative HBVsAg Test


US patients with Chronic Hepatitis B can now access quantitative test to help assess response to antiviral therapy

Quest Diagnostics Chairman, President and CEO Steve Rusckowski discusses health care issues with Fox Business Network's Maria Bartiromo

Quest CEO Discusses ACA & More with Fox, Bloomberg


Quest’s Steve Rusckowski tapped to discuss national health care issues

NY Giants Mark Herzlich Uses Lab Testing to Achieve Excellence


Heading into the playoffs the linebacker uses Blueprint for Athletes to gain insights.

Quest CEO Discusses Future Path with Modern Healthcare


Steve Rusckowski discusses the company’s goals and future and more in a Q&A with Modern Healthcare.

Quest & Safeway: A Growing Partnership

Better Health

Committed to improving the convenience of the diagnostic experience for patients, we’re expanding our presence with Patient Service Centers inside Safeway supermarket locations.

Quest Rings NYSE Closing Bell


In advance of our 20th anniversary of being listed on the New York Stock Exchange and our 50th anniversary as a company, on November 14, Quest Diagnostics President and CEO Steve Rusckowski was joined in New York by employees from around the country to ring the closing bell. Along with the 4 p.m. ceremony that […]

World Diabetes Day

How Innovative Digital Programs Can Help Reduce Type 2 Diabetes Risk

Better Health

Diabetes Awareness Month (November) and World Diabetes Day (November 14) not only bring awareness to a condition that affects 1 in 11 people, but also provide an opportunity for reflection about health, wellness, and the risk factors for type 2 diabetes. According to the American Diabetes Association (ADA), at least 86 million Americans are at […]

Quest Discusses Accelerating Growth, Operational Excellence with Investors


Members of the Quest Diagnostics senior management team present the company’s new two-point strategy to analysts and investors.

Load More